Revolution Medicines, Inc.
RVMDAPI behind this page
RVMD FY 2025 request
Playground key active
/api/financials?ticker=RVMD&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Research & Development | 987,332 | 592,225 | +66.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 987,332 | 592,225 | +66.7% |
| General & Administrative | 195,037 | 97,299 | +100.5% |
| Operating Expenses | 1,182,369 | 689,524 | +71.5% |
| Operating Income | -1,182,369 | -689,524 | -71.5% |
| Interest Income | 90,694 | 86,883 | +4.4% |
| Interest Expense | -24,231 | — | — |
| Change In Fair Value Of Warrant Liability And Contingent Earn Out Shares | -15,358 | 4,323 | -455.3% |
| Other Nonoperating Expense | -37 | -2,528 | +98.5% |
| Non-Operating Income (Expense) | 51,068 | 88,678 | -42.4% |
| Income Before Taxes | -1,131,301 | -600,846 | -88.3% |
| Net Income | -1,131,301 | -600,093 | -88.5% |
Show Equity Components breakouts |
|||
| Retained Earnings | -1,131,301 | -600,093 | -88.5% |
| EPS (Basic) | -5.95 | -3.58 | -66.2% |
| EPS (Diluted) | -5.95 | -3.58 | -66.2% |
| Wtd Avg Shares (Basic) | 190,129,154 | 167,737,672 | +13.3% |
| Wtd Avg Shares (Diluted) | 190,129,154 | 167,737,672 | +13.3% |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 1,916 | 777 | +146.6% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 1,916 | 777 | +146.6% |
| Comprehensive Income | -1,129,385 | -599,316 | -88.4% |
| Net Income Loss Available To Common Stockholders Basic | -1,131,301 | -600,093 | -88.5% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 383,745 | 543,064 | -29.3% |
| Marketable Securities (Current) | 1,641,934 | 1,746,235 | -6.0% |
| Prepaid Expenses & Other Current Assets | 49,358 | 38,333 | +28.8% |
| Total Current Assets | 2,075,037 | 2,327,632 | -10.9% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 33,194 | 24,289 | +36.7% |
| Operating Lease Right-of-Use Assets | 132,084 | 117,534 | +12.4% |
| Goodwill | 14,608 | 14,608 | 0.0% |
| Restricted Cash Noncurrent | 4,858 | 3,698 | +31.4% |
Show Credit Facility breakouts |
|||
| Letter Of Credit | 4.9 | 3.7 | +32.4% |
| Deposits Assets Noncurrent | 24,148 | 12,128 | +99.1% |
| Other Non-Current Assets | 14,779 | 1,742 | +748.4% |
| Total Assets | 2,354,508 | 2,558,301 | -8.0% |
| Other Assets | |||
| Intangible Assets Net Excluding Goodwill | 55,800 | 56,670 | -1.5% |
| Current Liabilities | |||
| Accounts Payable | 64,616 | 54,427 | +18.7% |
| Accrued Expenses And Other Current Liabilities | 209,340 | 96,615 | +116.7% |
| Operating Lease Liability Current | 16,468 | 12,872 | +27.9% |
| Total Current Liabilities | 290,424 | 163,914 | +77.2% |
| Accrued Liabilities | 5 | — | — |
| Non-Current Liabilities | |||
| Deferred Tax Liabilities | 2,353 | 2,353 | 0.0% |
| Operating Lease Liabilities | 142,234 | 122,971 | +15.7% |
| Accrued Royalties Current And Noncurrent | 268,446 | — | — |
| Other Non-Current Liabilities | 1,208 | 670 | +80.3% |
| Total Liabilities | 723,211 | 293,097 | +146.7% |
| Other Liabilities | |||
| Warrant Liability | 18,546 | 3,189 | +481.6% |
| Stockholders' Equity | |||
| Common Stock | 19 | 18 | +5.6% |
| Additional Paid In Capital Common Stock | 4,497,143 | 4,001,666 | +12.4% |
| Accumulated Other Comprehensive Income | 3,237 | 1,321 | +145.0% |
| Retained Earnings | -2,869,102 | -1,737,801 | -65.1% |
| Total Stockholders' Equity | 1,631,297 | 2,265,204 | -28.0% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 3,237 | 1,321 | +145.0% |
| Additional Paid In Capital | 4,497,143 | 4,001,666 | +12.4% |
| Common Stock | 19 | 18 | +5.6% |
| Retained Earnings | -2,869,102 | -1,737,801 | -65.1% |
| Total Liabilities & Equity | 2,354,508 | 2,558,301 | -8.0% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -1,131,301 | -600,093 | -88.5% |
| Gain Loss On Sale Of Property Plant Equipment | 32 | 118 | -72.9% |
| Amortization Of Intangible Assets | 870 | 1,069 | -18.6% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 870 | 1,069 | -18.6% |
| Stock-Based Compensation | 118,389 | 79,197 | +49.5% |
| Depreciation Amortization And Accretion Net | 7,780 | 6,559 | +18.6% |
| Fair Value Adjustment Of Warrants | 15,358 | -4,323 | +455.3% |
| Paid In Kind Interest | 24,231 | — | — |
| Accretion Amortization Of Discounts And Premiums Investments | -27,831 | -44,565 | +37.5% |
| Operating Lease Right Of Use Asset Amortization Expense | 7,908 | 4,196 | +88.5% |
| Change in Prepaid & Other Assets | -9,667 | -9,698 | +0.3% |
| Change in Accounts Payable | 9,535 | -6,465 | +247.5% |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 112,267 | 21,985 | +410.7% |
| Increase Decrease In Operating Lease Liability | -957 | -245 | -290.6% |
| Increase Decrease In Deposit Other Assets | -12,020 | -7,563 | -58.9% |
| Increase Decrease In Other Noncurrent Assets | -12,872 | 1,688 | -862.6% |
| Change in Other Liabilities | 537 | 212 | +153.3% |
| Net Cash from Operations | -897,741 | -557,436 | -61.0% |
| Investing Activities | |||
| Payments To Acquire Marketable Securities | -1,794,850 | -2,136,623 | +16.0% |
| Proceeds From Maturity Of Marketable Securities | 1,922,514 | 1,592,537 | +20.7% |
| Proceeds From Sale And Maturity Of Marketable Securities | 6,384 | — | — |
| Capital Expenditures | -15,990 | -10,308 | -55.1% |
| Net Cash from Investing | 118,058 | -554,394 | +121.3% |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 22,458 | 44,581 | -49.6% |
| Financing Activities | |||
| Proceeds From The Sale Of Future Royalties Net Of Issuance Costs | 244,215 | — | — |
| Proceeds From Issuance Of Common Stock (FY) | — | — | — |
Show Equity Components breakouts |
|||
| Common Stock · 2024 ATM Program | 347.9 | 59.5 | +484.7% |
| Proceeds From Issuance Of Common Stock From At The Market Offering | 347,915 | 118,728 | +193.0% |
| Proceeds From Stock Options Exercised | 21,134 | 12,330 | +71.4% |
| Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan | 8,036 | 5,029 | +59.8% |
| Proceeds From Warrant Exercises | 4 | — | — |
| Payments Of Deferred Offering Costs | 220 | 284 | -22.5% |
| Net Cash from Financing | 621,524 | 959,413 | -35.2% |
| Debt Issuance Costs | 5.8 | — | — |
| Amortization of Financing Costs | 541 | — | — |
| Supplemental | |||
| Unpaid Capital Expenditures | 1,876 | 1,576 | +19.0% |
| Other Cash Flow | |||
| Net Change in Cash | -158,159 | -152,417 | -3.8% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 388,603 | 546,762 | -28.9% |
| Restricted Cash | 4,858 | 3,698 | +31.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 388,603 | 546,762 | -28.9% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.